Feedback
Drug Panel 7, Urine - Screen with Reflex to Confirmation/Quantitation
0092184
Ordering Recommendation

Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out drug exposure.

Mnemonic
CDASU 7
Methodology
Qualitative Enzyme Multiplied Immunoassay Technique/ Quantitative Gas Chromatography-Mass Spectrometry/Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun-Sat
Reported
1-4 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Random urine. 
Specimen Preparation
Transfer 8 mL urine with no additives or preservative to ARUP Standard Transport Tubes. (Min: 4 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
Specimens exposed to repeated freeze/thaw cycles. 
Remarks
 
Stability
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years 
Reference Interval
Effective August 17, 2015
Drugs Covered and Cutoff Concentrations
Drugs/Drug Classes
Screen
THC (Cannabinoids)20 ng/mL
Cocaine150 ng/mL
Opiates300 ng/mL
Oxycodone100 ng/mL
Phencyclidine25 ng/mL
Amphetamines300 ng/mL
MDMA (Ecstasy)500 ng/mL
Barbiturates200 ng/mL
Benzodiazepines200 ng/mL

Interpretive Data
The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. Specimens for which drugs or drug classes are detected by the screen are reflexed to a second, more specific technology (GC/MS and/or LC-MS/MS). The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

For medical purposes only; not valid for forensic use.

Oxycodone results are reported with the opiates results. MDMA results are reported with the amphetamines results.

Note
If the specimen screens positive, then Confirmation/Quantitation by GC/MS and/or LC-MS/MS will be added to confirm result. Additional charges apply.
CPT Code(s)
80301; if positive, add appropriate CPT code(s): 80324; 80359; 80353; 80346; 80345; 80349; 80361; 80365; 83992 (Alt code: G0479; if positive, add appropriate CPT code(s): G0480)
Components
Component Test Code*Component Chart NameLOINC
0090386Creatinine, Urine2161-8
0090407CDASU 7 Comments
0092191Amphetamines, Urn, Screen19348-2
0092192Cocaine, Urn, Screen19363-1
0092193Opiates, Urn, Screen19300-3
0092194Phencyclidine, Urn, Screen19661-8
0092195THC, Urn, Screen19292-2
0092196Barbiturates, Urn, Screen19276-5
0092197Benzodiazepines, Urn, Screen19284-9
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Amphetamines, Urine
  • Barbiturates, Urine
  • Benzodiazepines, Urine
  • Cocaine, Urine
  • Creatinine, Urine
  • Marijuana, Urine
  • Opiates, Urine
  • Pain Management
  • Phencyclidine, Urine